Target Peptide Binding
Target Peptide Binding - Related Videos
14:28
Peptide-based Identification of Functional Motifs and their Binding Partners
0 Views •
Cited by 2 •
2013
Techniques to dissect the mechanisms underlying the secretion of HIV-1 Nef in exosomes are described. Specific short peptides derived from Nef and protein transfection were exploited to determine the structure, function, and binding partners of Nef’s Secretion Modification Region. These procedures have general relevance in many mechanistic studies.
07:59
A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes
0 Views •
Cited by 21 •
2014
Biochemical assays with recombinant human MHC II molecules can provide rapid, quantitative insights into immunogenic epitope identification, deletion, or design. Here, a peptide-MHC II binding assay scaled to 384-well plates is described. This cost effective format should prove useful in the fields of protein deimmunization and vaccine design and development.
05:15
Target Peptide Detection and Measurement Using a Capacitive Immunoprobe Biosensor
0 Views •
2025
This video demonstrates a method for detecting and quantifying peptide transmitters using a capacitive immunoprobe biosensor. The functionalized electrode, coated with antibodies, interacts with peptides of interest, leading to a signal change that allows precise measurement and detection of peptides.
06:54
MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
0 Views •
Cited by 3 •
2013
To demonstrate MR cancer molecular imaging with a small peptide targeted MRI contrast agent specific to clotted plasma proteins in tumor stroma in a mouse prostate cancer model.
09:34
Identification of Modified Histones as Binding Substrates of Human Spindlin Family Member 4 (SPIN4) by Peptide Arrays and Native Nucleosome Pulldown
0 Views •
2026
Genetic variants in human Spindlin Family Member 4 (SPIN4) have recently been identified in patients with bone overgrowth, a novel developmental disorder. A protocol and new results describing the biochemical identification of modified histones in the context of nucleosomes as SPIN4 binding substrates are presented.
FAQs
Anchor residues fit into defined positions within the MHC binding groove and help stabilize the peptide-MHC complex. Their compatibility with the groove affects whether the peptide remains positioned for immune recognition. Consequently, anchor-residue patterns can help distinguish peptides more likely to support antigen presentation from those that bind weakly or form less stable complexes.
Binding strength depends on the combined effects of complementary shape, charge, hydrophobicity, and hydrogen bonding between peptide residues and the target site. These interactions position the peptide and influence complex stability rather than acting independently. Changes in residue properties can therefore alter affinity, retention, and the likelihood that the complex supports reliable molecular recognition.
The molecular target determines how peptide association is interpreted. With MHC molecules, binding supports antigen presentation and depends strongly on peptide placement in the groove. Antibody or receptor binding instead provides a basis for recognition or affinity measurement. Comparing these target types helps separate peptide presentation from other forms of immune detection and molecular interaction.
Binding strength indicates how favorably a peptide associates with its target, while complex stability reflects how well that association persists. Considering both properties gives a more informative assessment than either measure alone. In infection research, this distinction supports comparison of immune targets and helps identify peptide-MHC complexes that may be more relevant to antigen presentation.
Researchers can compare peptide binding strength and complex stability to identify antigenic epitopes, meaning peptide regions capable of serving as immune targets. These measurements also allow systematic comparison among candidate targets and can inform evaluation of vaccine candidates. The resulting binding profile provides molecular evidence for prioritizing peptides for further immune-response investigation.
Peptide binding analysis connects molecular interactions with how pathogens are detected by adaptive immunity. In particular, MHC-associated measurements can support predictions of T-cell responses by showing which peptide targets form sufficiently stable complexes for antigen presentation. The approach also helps interpret differences among pathogen-derived targets and guides the design of infection-research assays.